The extracellular matrix: At the center of it all

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 3, 2010, Pages 474-482

  Bowers, Stephanie L K ^a   Banerjee, Indroneal ^a   Baudino, Troy A ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Cardiac development; Cardiac fibroblasts; Cardiac function; Cardiomyocytes; Cell heterogeneity; Endothelial cells; Extracellular matrix (ECM)

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN 1; FIBRONECTIN; GALECTIN 3; GAP JUNCTION PROTEIN; INTEGRIN LINKED KINASE; INTERLEUKIN 6; LAMININ; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; CARDIOVASCULAR INFLAMMATION; CELL COMMUNICATION; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; COLLAGEN DEGRADATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART DEVELOPMENT; HEART FAILURE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; MACROPHAGE ACTIVATION; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE; SPECIES DIFFERENCE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; HEART; HUMANS; MALE; MODELS, BIOLOGICAL; MYOCARDIUM; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION;

EID: 77649270920     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.08.024     Document Type: Review

References (67)

1. Davis G.E., Senger D.R. Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression. Curr. Opin. Hematol. 2008, 15:197-203.
2. Schor S.L., Schor A.M. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res. 2001, 3:373-379.
3. Weber K.T. From inflammation to fibrosis: a stiff stretch of highway. Hypertension 2004, 43:716-719.
4. Larue L., Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 2005, 24:7443-7454.
5. Manasek F.J. Embryonic development of the heart. II. Formation of the epicardium. J. Embrol. Exp. Morphol. 1969, 22:333-348.
6. Norris R.A., Borg T.K., Butcher J.T., Baudino T.A., Banerjee I., Markwald R.R. Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Ann. N.Y. Acad. Sci. 2008, 1123:30-40.
7. Huang J.X., Potts J.D., Vincent E.B., Weeks D.L., Runyan R.B. Mechanisms of cell transformation in the embryonic heart. Ann. N.Y. Acad. Sci. 1995, 752:317-330.
8. Runyan R.B., Potts J.D., Sharma R.V., Loeber C.P., Chiang J.J., Bhalla R.C. Signal transduction of a tissue interaction during embryonic heart development. Cell Regul. 1990, 1:301-313.
9. Sridurongrit S., Larsson J., Schwartz R., Ruiz-Lozano P., Kaartinen V. Signaling via the Tgf-β type I receptor Alk5 in heart development. Dev. Biol. 2008, 322:208-218.
10. Delot E.C. Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. Mol. Genet. Metab. 2003, 80:27-35.
11. Bernanke D.H., Markwald R.R. Effects of two glycosaminoglycans on seeding of cardiac cushion tissue cells into a collagen-lattice culture system. Anat. Rec. 1984, 210:25-31.
12. Butcher J.T., Markwald R.R. Valvulogenesis: the moving target. Philos. Trans. R. Soc. B 2007, 362:1489-1503.
13. Butcher J.T., Norris R.A., Hoffman S., Mjaatvedt C.H., Markwald R.R. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev. Biol. 2007, 302:256-266.
14. Schroeder J.A., Jackson L.F., Lee D.C., Camenisch T.D. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J. Mol. Med. 2003, 81:392-403.
15. Kruithof B.P.T., Krawitz S.A., Gaussin V. Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev. Biol. 2007, 302:208-217.
16. Beppu H., Malhotra R., Beppu Y., Lepore J.J., Parmacek M.S., Bloch K.D. BMP type II receptor regulates positioning of outflow tract and remodeling of atrioventricular cushion during cardiogenesis. Dev. Biol. 2009, 331:167-175.
17. Camelliti P., Borg T.K., Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 2005, 65:40-51.
18. Borg T.K., Caulfield J.B. Morphology of connective tissue in skeletal muscle. Tissue Cell 1980, 12:197-207.
19. Manabe I., Shindo T., Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ. Res. 2002, 91:1103-1113.
20. Corda S., Samuel J.L., Rappaport L. Extracellular matrix and growth factors during heart growth. Heart Fail. Rev. 2000, 5:119-130.
21. Jane-Lise S., Corda S., Chassagne C., Rappaport L. The extracellular matrix and the cytoskeleton in heart hypertrophy and failure. Heart Fail. Rev. 2000, 5:239-250.
22. Baudino T.A., Carver W., Giles W., Borg T.K. Cardiac fibroblasts: friend or foe?. Am. J. Physiol., Heart Circ. Physiol. 2006, 291:H1015-H1026.
23. Katsuragi N., Morishita R., Nakamura N., Ochiai T., Taniyama Y., Hasegawa Y., et al. Periostin as a novel factor responsible for ventricular dilation. Circulation 2004, 110:1806-1813.
24. MacKenna D., Summerour S.R., Villarreal F.J. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc. Res. 2000, 46:257-263.
25. Matsushita T., Oyamada M., Fujimoto K., Yasuda Y., Masuda S., Wada Y., et al. Remodeling of cell-cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. Circ. Res. 1999, 85:1046-1055.
26. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 2007, 87:1285-1342.
27. Ross R.S., Borg T.K. Integrins and the myocardium. Circ. Res. 2001, 88:1112-1119.
28. Graham H.K., Horn M., Trafford A.W. Extracellular matrix profiles in the progression to heart failure. European Young Physiologists Symposium Keynote Lecture-Bratislava 2007. Acta Physiol. (Oxf) 2008, 194:3-21.
29. Sussman M.A., McCulloch A., Borg T.K. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ. Res. 2002, 91:888-898.
30. Burgess M.L., Buggy J., Price R.L., Abel F.L., Terracio L., Samarel A.M., et al. Exercise- and hypertension-induced collagen changes are related to left ventricular function in rat hearts. Am. J. Physiol. 1996, 270:H151-H159.
31. Banerjee I., Fuseler J.W., Price R.L., Borg T.K., Baudino T.A. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am. J. Physiol., Heart Circ. Physiol. 2007, 293:H1883-H1891.
32. Mueller X.M., Tevaearai H.T., Tucker O., Boone Y., von Segesser L. Reshaping the remodelled left ventricle: a new concept. Eur. J. Cardio-thorac. Surg. 2001, 20:786-791.
33. Edwards C.A., O'Brien W.D. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin. Chim. Acta 1980, 104:161-167.
34. Li F., Wang X., Capasso J.M., Gerdes A.M. Transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 1996, 28:1737-1746.
35. Dobacewski M., Bujak M., Zymek P., Ren G., Entman M.L., Frangogiannis N.G. Extracellular matrix remodeling in canine and mouse myocardial infarcts. Cell Tissue Res. 2006, 324:475-488.
36. Villar A.V., Llano M., Cobo M., Espósito V., Merino R., Martín-Durán R., et al. Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy. J. Mol. Cell. Cardiol. 2009, 46:526-535.
37. Liu H., Chen B., Lilly B. Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1. Angiogenesis 2008, 11:223-234.
38. Humphries J.D., Byron A., Humphries M.J. Integrin ligands at a glance. J. Cell. Sci. 2006, 119:3901-3903.
39. Ieda M., Tsuchihashi T., Ivey K.N., Ross R.S., Hong T.T., Shaw R.M., et al. Cardiac fibroblasts regulate myocardial proliferation through β1 integrin signaling. Dev. Cell 2009, 16:233-244.
40. Sun M., Opavsky M.A., Steward D.J., Rabinovitch M., Dawood F., Wen W., et al. Temporal response and localization of integrins β1 and β3 in the heart after myocardial infarction: regulation by cytokines. Circ 2003, 107:1046-1052.
41. Fielding A.B., Dobreva I., Dedhar S. Beyond focal adhesions: integrin-linked kinase associates with tubulin and regulates mitotic spindle organization. Cell Cycle 2008, 7:1899-1906.
42. Astrof S., Hynes R.O. Fibronectins in vascular morphogenesis. Angiogenesis 2009, 12:165-175.
43. Peacock J.D., Lu Y., Koch M., Kadler K.E., Lincoln J. Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance. Dev. Dyn. 2008, 237:3038-3051.
44. Sarkar S., Vellaichamy E., Young D., Sen S. Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. Am. J. Physiol., Heart Circ. Physiol. 2004, 287:H107-H117.
45. Liu J., He X., Corbett S.A., Lowry S.F., Graham A.M., Fassler R., et al. Integrins are required for the differentiation of visceral endoderm. J. Cell. Sci. 2008, 122:233-242.
46. Kohl P., Camelliti P., Burton F.L., Smith G.L. Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation. J. Electrocardiol. 2005, 38:45-50.
47. Sachse F.B., Moreno A.P., Abildskov J.A. Electrophysiological modeling of fibroblasts and their interaction with myocytes. Ann. Biomed. Eng. 2008, 36:41-56.
48. Mjaatvedt C.H., Kern C.B., Norris R.A., Fairey S., Cave C.L. Normal distribution of melanocytes in the mouse heart. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 2005, 285:748-757.
49. Litvin J., Zhu S., Norris R., Markwald R. Periostin family of proteins: therapeutic targets for heart disease. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 2005, 287:1205-1212.
50. Lindsley A., Li W., Wang J., Maeda N., Rogers R., Conway S.J. Comparison of the four mouse fasciclin-containing genes expression patterns during valvuloseptal morphogenesis. Gene Expr. Patterns 2005, 5:593-600.
51. Snider P., Hinton R.B., Moreno-Rodriguez R.A., Wang J., Rogers R., Lindsley A., et al. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ. Res. 2008, 102:752-760.
52. Lindner V., Wang Q., Conley B.A., Friesel R.E., Vary C.P.H. Vascular injury induces expression of periostin implications for vascular cell differentiation and migration. Arterioscler. Thromb. Vasc. Biol. 2005, 25:77-83.
53. Banerjee I., Fuseler J.W., Intwala A.R., Baudino T.A. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density and dramatically alters the cell populations of the developing and adult heart. Am. J. Physiol., Heart Circ. Physiol. 2009, 296:H1694-H1704.
54. Kühn B., delMonte F., Hajjar R.J., Chang Y.S., Lebeche D., Arab S., et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 2007, 13:962-969.
55. Li P., Oparil S., Feng W., Chen Y.F. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct pathways in rat pulmonary arterial smooth muscle cells. J. Appl. Physiol. 2004, 97:1550-1558.
56. Lorts A., Schwanekamp J.A., Elrod J.W., Sargent M.A., Molkentin J.D. Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell activity or cardiac repair. Circ Res 2009, 104:e1-7.
57. Li Y.Y., McTiernan C.F., Feldman A.M. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc. Res. 2000, 46:214-224.
58. Lindsey M.L., Goshorn D.K., Squires C.E., Escobar G.P., Hendrick J.W., Mingoia J.T., et al. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc. Res. 2005, 66:410-419.
59. Peterson J.T., Li H., Dillon L., Bryant J.W. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 2000, 46:307-315.
60. Lindsey M.L., Escobar G.P., Mukherjee R., Goshorn D.K., Sheats N.J., Bruce J.A., et al. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 2006, 113:2919-2928.
61. Maquart F.X., Bellon G., Pasco S., Monboisse J.C. Matrikines in the regulation of extracellular matrix degradation. Biochimie 2005, 87:353-360.
62. Davis G.E., Bayless K.J., Davis M.J., Meininger G.A. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am. J. Pathol. 2000, 156:1489-1498.
63. Robinet A., Millart H., Oszust F., Hornebeck W., Bellon G. Binding of elastin peptides to S-Gal protects the heart against ischemia/reperfusion injury by triggering the RISK pathway. FASEB J. 2007, 21:1968-1978.
64. Mann D.L. Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu. Rev. Physiol. 2003, 65:81-101.
65. Hirota H., Izumi M., Hamaguchi T., Sugiyama S., Murakami E., Kunisada K., et al. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure. Heart Vessels 2004, 19:237-241.
66. Mironov V., Visconti R.P., Kasyanov V., Forgacs G., Drake C.J., Markwald R.R. Organ printing: tissue spheroids as building blocks. Biomaterials 2009, 30:2164-2174.
67. Geisse N.A., Sheehy S.P., Parker K.K. Control of myocyte remodeling in vitro with engineered substrates. In Vitro Cell. Dev. Biol., Anim. 2009, 45:343-350.